Suggestions
Daniela van Eickels
Executive Director Global Medical Affairs bei Kite Pharma
Daniela van Eickels, MD, MPH, is a prominent figure in the field of cell therapy and medical affairs. She currently holds the position of Vice President and Head of Medical Affairs for Bristol Myers Squibb's Cell Therapy Organization.45 In this role, she is actively involved in advancing cell therapy research and development, particularly for autoimmune diseases.
Career Highlights
-
Leadership in ACTioN: Dr. van Eickels serves as a co-chair of ACTioN (Autoimmunity Cell Therapy Network), a global collaborative effort by Bristol Myers Squibb to accelerate the development of cell therapies for autoimmune diseases.12
-
Expertise in Cell Therapy: She is deeply involved in the application of CAR T-cell therapy, which has shown success in treating certain blood cancers, to autoimmune diseases.1
-
Medical Affairs Leadership: At Bristol Myers Squibb, she leads medical affairs efforts in the cell therapy organization, focusing on expanding the potential of these treatments.45
Research and Development Focus
Dr. van Eickels is particularly interested in:
- Transferring the concept of selectively targeting cells from cancer treatment to autoimmune diseases.1
- Addressing unmet needs in autoimmune disease treatment through cell therapy.5
- Facilitating interdisciplinary collaboration among scientists, clinicians, and patient advocates to advance cell therapy research.1
Professional Background
While her current role is with Bristol Myers Squibb, it's worth noting that her LinkedIn profile suggests previous experience at Kite Pharma, which is now part of Gilead Sciences.3 However, the most recent and prominent information indicates her leadership position at Bristol Myers Squibb's Cell Therapy Organization.
Dr. van Eickels is actively involved in presenting and discussing the potential of cell therapies for autoimmune diseases at professional conferences and in medical publications.45